glp/gip/glucagon & cagrilintide GIPR/GLP-1R dual agonist therapies for diabetes and weight loss—chemistry, physiology, and clinical applications Semaglutide, a glucagon-like peptide-1 (GLP-1)
Description
M., Lei, W., Keresztes, A., LaVigne, J
Gastroenterology 152, 14071418, doi: 10.1053/j.gastro.2017.01.005 (2017)
We expect this to trend down as visceral fat decreases, since visceral fat is itself a driver of chronic inflammation
The amount of force required was defined as the mean of three measurements made at 5-min intervals
